Related Articles
Glucagon‑like peptide‑1 protects cardiomyocytes from advanced oxidation protein product‑induced apoptosis via the PI3K/Akt/Bad signaling pathway
Exendin-4, a glucagon‑like peptide‑1 receptor agonist, inhibits hyperglycemia‑induced apoptosis in myocytes by suppressing receptor for advanced glycation end products expression
Hydroxytyrosol promotes autophagy by regulating SIRT1 against advanced oxidation protein product‑induced NADPH oxidase and inflammatory response
Advanced oxidation protein products aggravate age‑related bone loss by increasing sclerostin expression in osteocytes via ROS‑dependent downregulation of Sirt1
Effect of advanced oxidation protein products on the proliferation and osteogenic differentiation of rat mesenchymal stem cells